2011
DOI: 10.3109/00207454.2010.541571
|View full text |Cite
|
Sign up to set email alerts
|

Sominone Improves Memory Impairments and Increases Axonal Density in Alzheimer's Disease Model Mice, 5XFAD

Abstract: Previously we showed that steroidal sapogenin, sominone improved memory after a single i.p. injection into normal mice. However, it had not been reported that sominone could recover memory deficits in a severe Alzheimer's disease (AD) model animal. Therefore, we aimed to investigate that sominone improved memory impairments in the 5XFAD mouse, model for AD. In the current study, we used sominone that we had synthesized. 5XFAD mice were given 10 μmol/kg sominone intraperitoneally for 9 days. In addition to obje… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
21
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
5
4

Relationship

4
5

Authors

Journals

citations
Cited by 28 publications
(24 citation statements)
references
References 25 publications
3
21
0
Order By: Relevance
“…42) Memory deficits in 5XFAD mice were demonstrated after 4 months old by contextual fear conditioning 43) and Y-maze test. 41) We additionally confirmed impairment of spatial memory 44) and object recognition memory 45,46) in these mice.…”
Section: Diosgenin Its Activities and Signaling Pathwaysupporting
confidence: 61%
“…42) Memory deficits in 5XFAD mice were demonstrated after 4 months old by contextual fear conditioning 43) and Y-maze test. 41) We additionally confirmed impairment of spatial memory 44) and object recognition memory 45,46) in these mice.…”
Section: Diosgenin Its Activities and Signaling Pathwaysupporting
confidence: 61%
“…administration of sominone increased axonal density in the brain and improved object recognition memory impairment. 27) These results suggest that withanoside IV is metabolized to its active principle sominone after oral administration, which subsequently induces marked recovery of neurites, synapses, and memory. These data suggest that withanoside IV and its metabolite sominone are potential drugs against Alzheimer's disease.…”
Section: Axon Regeneration and Synaptic Reconstructionmentioning
confidence: 83%
“…Further studies of Ashwagandha will probably contribute to resolving an urgent unmet medical need: efficacious treatments that may offer cure of neurodegenerative diseases. 17) Memory improvement 38) Neuroprotective effects in vitro 33,35) Aβ clearance in vivo 38) Withanolide A Neurite outgrowth in vitro 18,19) Axonal regeneration and synaptic reconstruction in vitro and in vivo 21) Memory improvement 21) Upregulation of BACE1, ADAM10 and IDE in vitro 31) Withanoside IV Neurite outgrowth in vitro 18,19) Axonal regeneration and synaptic reconstruction in vitro and in vivo 22) Memory improvement 22) Withanoside VI Neurite outgrowth in vitro 18,19) Axonal regeneration and synaptic reconstruction in vitro and in vivo 23) Memory improvement 23) Sominone Axonal regeneration and synaptic reconstruction in vitro 22) Axonal growth in vivo 28) Memory improvement 27) and memory enhancement 28) Denosomin Axonal regeneration and neuroprotective effect in vitro 45) Withanone Neuroprotective effects in vitro 35) Spinal cord injury Withanoside IV Axonal growth in vivo and functional recovery 43) Denosomin Axonal growth in vivo and functional recovery 45) Parkinson's disease Extract Anti-oxidant effect in vivo [55][56][57][58][59] Neuroprotective effect in vivo 55,59) Functional recovery [55][56][57][58][59] Huntington's disease Extract Anti-oxidant ef...…”
Section: Resultsmentioning
confidence: 99%
“…In addition to memory deficits in 5XFAD shown by contextual fear conditioning (Ohno, 2009) and Y-maze , we clarified impairments of spatial memory (Urano & Tohda, 2010) and object recognition memory (Joyashiki, Matsuya, & Tohda, 2011) in 5XFAD. Therefore, the aim of this study is to investigate the effects of KKT on memory deficits in 5XFAD.…”
Section: Introductionmentioning
confidence: 94%